Codexis (CDXS)
(Delayed Data from NSDQ)
$2.69 USD
+0.01 (0.37%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $2.68 -0.01 (-0.37%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CDXS 2.69 +0.01(0.37%)
Will CDXS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CDXS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CDXS
Regeneron (REGN) Tops Q2 Earnings and Revenue Estimates
Codexis (CDXS) Reports Q1 Loss, Misses Revenue Estimates
CDXS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates
Immunome, Inc. (IMNM) Reports Q1 Loss, Tops Revenue Estimates
Codexis (CDXS) Expected to Beat Earnings Estimates: Should You Buy?
Other News for CDXS
Codexis to Report Second Quarter 2025 Financial Results on August 13 | CDXS Stock News
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
Opaleye Management Inc. Increases Stake in Codexis Inc.
Opaleye Management Makes a Bold Move with Codexis Stock Purchase!